These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 29971911)
1. Long non-coding RNA FTH1P3 activates paclitaxel resistance in breast cancer through miR-206/ABCB1. Wang R; Zhang T; Yang Z; Jiang C; Seng J J Cell Mol Med; 2018 Sep; 22(9):4068-4075. PubMed ID: 29971911 [TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA CASC2 promotes paclitaxel resistance in breast cancer through regulation of miR-18a-5p/CDK19. Zheng P; Dong L; Zhang B; Dai J; Zhang Y; Wang Y; Qin S Histochem Cell Biol; 2019 Oct; 152(4):281-291. PubMed ID: 31352515 [TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA MEG3 suppresses cell proliferation, migration and invasion, induces apoptosis and paclitaxel-resistance via miR-4513/PBLD axis in breast cancer cells. Zhu M; Wang F; Mi H; Li L; Wang J; Han M; Gu Y Cell Cycle; 2020 Dec; 19(23):3277-3288. PubMed ID: 33121324 [TBL] [Abstract][Full Text] [Related]
4. UCA1 confers paclitaxel resistance to ovarian cancer through miR-129/ABCB1 axis. Wang J; Ye C; Liu J; Hu Y Biochem Biophys Res Commun; 2018 Jul; 501(4):1034-1040. PubMed ID: 29777711 [TBL] [Abstract][Full Text] [Related]
5. Circ-RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR-140-5p. Zang H; Li Y; Zhang X; Huang G Thorac Cancer; 2020 Jul; 11(7):1891-1903. PubMed ID: 32445273 [TBL] [Abstract][Full Text] [Related]
6. lncRNA NEAT1 promotes the Taxol resistance of breast cancer via sponging the miR-23a-3p-FOXA1 axis. Zhu L; Wang F; Fan W; Jin Z; Teng C; Zhang J Acta Biochim Biophys Sin (Shanghai); 2021 Aug; 53(9):1198-1206. PubMed ID: 34327529 [TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA BLACAT1 modulates ABCB1 to promote oxaliplatin resistance of gastric cancer via sponging miR-361. Wu X; Zheng Y; Han B; Dong X Biomed Pharmacother; 2018 Mar; 99():832-838. PubMed ID: 29710482 [TBL] [Abstract][Full Text] [Related]
8. SNHG5 enhances Paclitaxel sensitivity of ovarian cancer cells through sponging miR-23a. Lin H; Shen L; Lin Q; Dong C; Maswela B; Illahi GS; Wu X Biomed Pharmacother; 2020 Mar; 123():109711. PubMed ID: 31884343 [TBL] [Abstract][Full Text] [Related]
9. Linc00518 Contributes to Multidrug Resistance Through Regulating the MiR-199a/MRP1 Axis in Breast Cancer. Chang L; Hu Z; Zhou Z; Zhang H Cell Physiol Biochem; 2018; 48(1):16-28. PubMed ID: 30001527 [TBL] [Abstract][Full Text] [Related]
10. Paeonol reverses paclitaxel resistance in human breast cancer cells by regulating the expression of transgelin 2. Cai J; Chen S; Zhang W; Hu S; Lu J; Xing J; Dong Y Phytomedicine; 2014 Jun; 21(7):984-91. PubMed ID: 24680370 [TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA H19 acts as a miR-340-3p sponge to promote epithelial-mesenchymal transition by regulating YWHAZ expression in paclitaxel-resistant breast cancer cells. Yan L; Yang S; Yue CX; Wei XY; Peng W; Dong ZY; Xu HN; Chen SL; Wang WR; Chen CJ; Yang QL Environ Toxicol; 2020 Sep; 35(9):1015-1028. PubMed ID: 32420678 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-155-5p promotes tumor progression and contributes to paclitaxel resistance via TP53INP1 in human breast cancer. Li Y; Zhang L; Dong Z; Xu H; Yan L; Wang W; Yang Q; Chen C Pathol Res Pract; 2021 Apr; 220():153405. PubMed ID: 33756128 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA 100 sensitizes luminal A breast cancer cells to paclitaxel treatment in part by targeting mTOR. Zhang B; Zhao R; He Y; Fu X; Fu L; Zhu Z; Fu L; Dong JT Oncotarget; 2016 Feb; 7(5):5702-14. PubMed ID: 26744318 [TBL] [Abstract][Full Text] [Related]
14. E2F1-induced ferritin heavy chain 1 pseudogene 3 (FTH1P3) accelerates non-small cell lung cancer gefitinib resistance. Zheng G; Chen W; Li W; Ding Y; Tu P; Chen W Biochem Biophys Res Commun; 2020 Oct; 530(4):624-631. PubMed ID: 32762943 [TBL] [Abstract][Full Text] [Related]
15. Effect of rs67085638 in long non-coding RNA (CCAT1) on colon cancer chemoresistance to paclitaxel through modulating the microRNA-24-3p and FSCN1. Xiao ZS; Zhao L; Zhang XN; Li HX; Yin ZH J Cell Mol Med; 2021 Apr; 25(8):3744-3753. PubMed ID: 33709519 [TBL] [Abstract][Full Text] [Related]
16. A1BG-AS1 promotes adriamycin resistance of breast cancer by recruiting IGF2BP2 to upregulate ABCB1 in an m6A-dependent manner. Wang J; Xu J; Zheng J Sci Rep; 2023 Nov; 13(1):20730. PubMed ID: 38007504 [TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA NNT-AS1 sponges miR-424/E2F1 to promote the tumorigenesis and cell cycle progression of gastric cancer. Chen B; Zhao Q; Guan L; Lv H; Bie L; Huang J; Chen XB J Cell Mol Med; 2018 Oct; 22(10):4751-4759. PubMed ID: 30006956 [TBL] [Abstract][Full Text] [Related]
18. miR-381 overcomes cisplatin resistance in breast cancer by targeting MDR1. Yi D; Xu L; Wang R; Lu X; Sang J Cell Biol Int; 2019 Jan; 43(1):12-21. PubMed ID: 30444043 [TBL] [Abstract][Full Text] [Related]
19. Differential altered expression of let-7a and miR-205 tumor-suppressor miRNAs in different subtypes of breast cancer under treatment with Taxol. Asghari F; Haghnavaz N; Shanehbandi D; Khaze V; Baradaran B; Kazemi T Adv Clin Exp Med; 2018 Jul; 27(7):941-945. PubMed ID: 30019863 [TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA FTH1P3 facilitates oral squamous cell carcinoma progression by acting as a molecular sponge of miR-224-5p to modulate fizzled 5 expression. Zhang CZ Gene; 2017 Apr; 607():47-55. PubMed ID: 28093311 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]